Supercritical fluid crystallization of griseofulvin: Crystal habit modification with a selective growth inhibitor

被引:37
作者
Jarmer, DJ
Lengsfeld, CS
Anseth, KS
Randolph, TW [1 ]
机构
[1] Univ Colorado, Ctr Pharmaceut Biotechnol, Dept Chem & Biol Engn, Boulder, CO 80309 USA
[2] Univ Denver, Dept Engn, Denver, CO USA
关键词
supercritical fluids; crystallization; crystal shape; excipients; biodegradable polymers; stability; formulation;
D O I
10.1002/jps.20463
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Poly (sebacic anhydride) (PSA) was used as a growth inhibitor to selectively modify habit of griseofulvin crystals formed via the Precipitation with a compressed-fluid antisolvent (PCA) process. PSA and griseofulvin were coprecipitated within a PCA injector, which provided efficient mixing between the solution and compressed antisolvent process streams. Griseofulvin crystal habit was modified from acicular to bipyramidal when the mass ratio of PSA/griseofulvin in the solution feed stream was <= 1: 1. The habit modification was attributed to the preferential adsorption of PSA to the fastest growing crystal face of the acicular crystal form, which inhibited growth. Scanning electron microscopy (SEM) was used to characterize the griseofulvin and PSA particles, and gave results consistent with a selective growth inhibition mechanism. SEM micrographs showed regions on griseofulvin crystals where PSA microparticles had preferentially adsorbed. X-ray powder diffraction (XRPD) and differential scanning calorimetry (DSC) analysis of the griseofulvin crystals indicated no changes in the crystalline form after the habit modification. Powder compressibility decreased from 49 +/- 3% to 28 +/- 7% with the modification in crystal habit. No change in the physical stability of the processed powder was observed after being stored at 25 degrees C/60% RH and 40 degrees C/70% RH for 23 days. Despite the change in crystal habit, griseofulvin crystals achieved 100% dissolution within 60 min in a simulated gastric fluid. (c) 2005 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:2688 / 2702
页数:15
相关论文
共 34 条
[1]   Control of the physical form of salmeterol xinofoate [J].
Beach, S ;
Latham, D ;
Sidgwick, C ;
Hanna, M ;
York, P .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1999, 3 (05) :370-376
[2]   POLYMERIC MICROSPHERES PREPARED BY SPRAYING INTO COMPRESSED CARBON-DIOXIDE [J].
BODMEIER, R ;
WANG, H ;
DIXON, DJ ;
MAWSON, S ;
JOHNSTON, KP .
PHARMACEUTICAL RESEARCH, 1995, 12 (08) :1211-1217
[3]   Analysis of the supersaturation and precipitation process with supercritical CO2 [J].
Bristow, S ;
Shekunov, T ;
Shekunov, BY ;
York, P .
JOURNAL OF SUPERCRITICAL FLUIDS, 2001, 21 (03) :257-271
[4]   PHYSICAL CHARACTERIZATION OF PHARMACEUTICAL SOLIDS [J].
BRITTAIN, HG ;
BOGDANOWICH, SJ ;
BUGAY, DE ;
DEVINCENTIS, J ;
LEWEN, G ;
NEWMAN, AW .
PHARMACEUTICAL RESEARCH, 1991, 8 (08) :963-973
[5]  
DOMB AJ, 1993, ADV POLYM SCI, V107, P93
[6]   POLYANHYDRIDES .1. PREPARATION OF HIGH-MOLECULAR-WEIGHT POLYANHYDRIDES [J].
DOMB, AJ ;
LANGER, R .
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 1987, 25 (12) :3373-3386
[7]   Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS™) [J].
Edwards, AD ;
Shekunov, BY ;
Kordikowski, A ;
Forbes, RT ;
York, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (08) :1115-1124
[8]  
FDA, 1998, GUID IND STAB TEST D
[9]  
FORD JL, 1991, ENCY PHARM TECHNOLOG, P121
[10]  
Garside J, 2000, MOL CRYSTALLIZERS IN